| Display title | Chemistry:PF-00446687 |
| Default sort key | PF-00446687 |
| Page length (in bytes) | 3,773 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 809460 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>S.Timg |
| Date of page creation | 05:01, 6 February 2024 |
| Latest editor | imported>S.Timg |
| Date of latest edit | 05:01, 6 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | PF-00446687 is a drug developed by Pfizer for the treatment of erectile dysfunction, which is a non-peptide agonist selective for the melanocortin receptor subtype MC4. It was found to be active in preliminary human trials, with the 200mg dose being of similar effectiveness to 100mg sildenafil, though... |
